Excellent
Fully Aligned
Patient Risk:
Low
Summary
The AI claim exactly matches the FDA boxed warning and related Warnings language to discontinue lisinopril/hydrochlorothiazide as soon as possible when pregnancy is detected due to fetal toxicity risk.
Category Scores
Accurate Statements
When pregnancy is detected, discontinue lisinopril and hydrochlorothiazide tablets as soon as possible due to fetal toxicity risk.
Supported by Boxed Warning: "When pregnancy is detected, discontinue lisinopril and hydrochlorothiazide tablets as soon as possible." and by Warnings: "When pregnancy is detected, discontinue lisinopril and hydrochlorothiazide tablets as soon as possible."
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated statement is an on-label, boxed-warning instruction consistent with FDA labeling.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement